Cao et al.’s [64] results showed that higher fasting IGF-binding protein (IGFBP-1) levels were associated with lower risk of prostate cancer, whereas higher IGF-1 levels were associated with increased prostate cancer risk. Here, IGF1 is linked to prostate carcinoma.